Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SkinBioTherapeutics ( (GB:SBTX) ) has shared an announcement.
SkinBioTherapeutics plc has successfully raised approximately £4.2 million through a combination of a Placing, Subscription, and WRAP Retail Offer, issuing a total of 24,704,836 new Ordinary Shares at 17 pence per share. This capital raise will support the company’s operational and strategic initiatives, with the new shares expected to be admitted to trading on AIM by 24 June 2025, thereby increasing the company’s total voting rights and share capital.
Spark’s Take on GB:SBTX Stock
According to Spark, TipRanks’ AI Analyst, GB:SBTX is a Neutral.
The overall score is driven predominantly by financial challenges and bearish technical indicators. However, positive corporate events provide some optimism for future growth.
To see Spark’s full report on GB:SBTX stock, click here.
More about SkinBioTherapeutics
SkinBioTherapeutics plc is a life science group focused on skin health, operating within the biotechnology industry. The company specializes in developing products that enhance skin health, targeting both consumer and healthcare markets.
Average Trading Volume: 1,579,295
Technical Sentiment Signal: Sell
Current Market Cap: £39.5M
Find detailed analytics on SBTX stock on TipRanks’ Stock Analysis page.